HIV Vaccines

Vaccine Data Presented at NIH Conference

Published in Vaccine Weekly, May 17th, 1999

Dr. Carl Wild, Boston Biomedica Inc., Biotech Research Laboratories, presented the latest results of Boston Biomedica's approach to HIV vaccine development at the U.S. National Institutes of Health (NIH) Conference, "New Concepts in HIV Vaccine Development," held in Bethesda, Maryland, May 3-5, 1999.

Over the past several years, it has become apparent that new approaches are required to develop an effective vaccine against HIV infection. Boston Biomedica's HIV vaccine program represents a proprietary approach to the generation of a prophylactic or therapeutic vaccine targeting this devastating virus, according to the company.

Wild and his...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Vaccine Weekly

Source: Vaccine Weekly (1999-05-17)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry